Envoy Medical (COCH) Cash from Financing Activities (2021 - 2026)

Envoy Medical's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $27.6 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 675.86% year-over-year to $27.6 million; the TTM figure through Mar 2026 stood at $40.7 million (up 134.64% YoY), while the FY2025 annual figure was $16.6 million, down 17.65% from the prior year.
• Cash from Financing Activities came in at $27.6 million for Q1 2026 at Envoy Medical, up from $6.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $27.6 million in Q1 2026 to a low of -$1.5 million in Q4 2023.
• A 5-year average of $5.5 million and a median of $4.0 million in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 76633.33% in 2022 and plunged 172.7% in 2023, its largest moves.
• Envoy Medical's Cash from Financing Activities stood at $2.0 million in 2022, then plunged by 172.7% to -$1.5 million in 2023, then jumped by 486.31% to $5.6 million in 2024, then advanced by 7.53% to $6.0 million in 2025, then surged by 356.52% to $27.6 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $27.6 million, $6.0 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison